Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Gov. Hochul announces the launch of phase two of New York's STAR program, assistant eligible homeowners who have school taxes ...

Scancell has linked iSCIB1+ to a 69% response rate in advanced melanoma, lead | Scancell has linked iSCIB1+ to a 69% response ...

Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the ...

We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Alkermes plc stands fourth on our list among the most ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

CALGARY, AB / ACCESS Newswire / July 22, 2025 / Primary Hydrogen Corp. (TSXV:HDRO)(FRA:83W0)(OTCQB:HNATF) ("Primary" or the ...

Alkermes’ investigational drug helped people with a type of narcolepsy stay awake during the day in a mid-stage trial.

Pinguecula is a benign, common degeneration of the conjunctiva that appears as a grey-white-yellow mass on the bulbar ...

Chamala Kiran Kumar Reddy, Congress MP from Bhongir, appealed to the Union urban affairs ministry to expedite approvals for ...

President John Dramani Mahama has emphasised the importance of responsive leadership, recounting how his previous ...

According to Audra Miller, community development director for Bryan County, portions of the current subdivision are in Zone X ...